LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients

NCT02631772 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Sofosbuvir/Ledipasvir x 12 weeks
DRUG: Sofosbuvir/Ledipasvir + Ribavirin x 12 weeks

Sponsor

Medical University of South Carolina